http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02268120-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14b02369b953bf4ebd31190c8cb63473 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
| filingDate | 1989-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e16b4f3f6801bdfcf68b56635446599d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49d4d4472130fdae9c792a05bd8e799 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fbd9ed5a6bade61c868fa7274787d61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db113e3818622e51d8528435e21b90a |
| publicationDate | 1990-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H02268120-A |
| titleOfInvention | Antitumor composition |
| abstract | PURPOSE: To obtain a composition useful as an anti-cancer drug, especially a remedy for leukemia, having excellent antitumor activity and low toxicity, comprising a specific polysaccharide compound prepared from root of Panax notogenseng. n CONSTITUTION: An antitumor composition which is obtained from root of Panax notogenseng and has the following characteristics. (a) White or light brown powder and slightly water-soluble. (b) Having 3,000-20,000 calculated as polyethylene glycol of molecular weight range and a main peak at 5,000 average molecular weight by gel filtration analysis through high performance liquid chromatography. (c) Having maximum absorption of infrared absorption of KBr tablet approximately at 3,423cm -1 , 1,636cm -1 etc., free from ultraviolet absorption in an aqueous solution. (d). Containing a polysaccharide comprising α-1,4 glucane, positive in phenol sulfuric acid reaction and negative in Elson- Morgan reaction in qualitative reaction of saccharide. The composition is orally or parenterally administered to human, a dose thereof is 0.01-5g per adult daily and administered once or dividedly 2-3 times. n COPYRIGHT: (C)1990,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012263806-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107814854-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06279292-A |
| priorityDate | 1989-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.